{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:44:38Z","timestamp":1785908678208,"version":"3.56.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Primary bladder neuroendocrine neoplasm (BNEN) is an uncommon but clinically aggressive malignancy, and evidence guiding its diagnosis and management remains limited. This retrospective study analyzed nine patients diagnosed with BNEN at a single institution between 2014 and 2024, with pathological classification confirmed by morphology and neuroendocrine immunohistochemical markers. Clinical features, histological subtypes, treatment strategies, and follow-up outcomes were reviewed. Most patients presented with painless gross hematuria and advanced-stage disease. Histologically, the cohort showed marked heterogeneity, including small cell neuroendocrine carcinoma (SCNEC), large cell neuroendocrine carcinoma (LCNEC), paraganglioma (PGL), and mixed neuroendocrine neoplasms. All cases expressed CD56 and synaptophysin, while Ki-67 indices indicated high proliferative activity in most tumors. Despite multimodal treatment, prognosis remained poor. Findings related to immunotherapy were preliminary and should be interpreted with caution. These findings highlight the aggressive and heterogeneous nature of BNEN and support individualized multimodal management, with further studies needed to clarify the role of immunotherapy.<\/jats:p>","DOI":"10.3389\/fonc.2026.1841019","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:48:50Z","timestamp":1785905330000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Clinicopathological features of bladder neuroendocrine neoplasm: a retrospective case series of nine cases and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Xinni","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongsong","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyin","family":"Teng","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Zhejiang University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqin","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, 920th Hospital of Joint Logistics Support Force of Chinese People\u2019s Liberation Army","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiang","family":"Wen","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuqing","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Central Lab, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhi","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qujing Second People\u2019s Hospital","place":["Qujing, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Qujing Second People\u2019s Hospital","place":["Qujing, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Center"},{"key":"B2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.clgc.2019.11.014","article-title":"Neuroendocrine carcinoma of the urinary bladder: a large, retrospective study from the French Genito-Urinary Tumor Group","volume":"18","author":"Sroussi","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/his.70044","article-title":"Neuroendocrine tumours of the urinary bladder: recent advances","volume":"88","author":"Akbulut","year":"2026","journal-title":"Histopathology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-016-9444-5","article-title":"Neuroendocrine tumors of the urinary bladder according to the 2016 World Health Organization classification: molecular and clinical characteristics","volume":"27","author":"Kouba","year":"2016","journal-title":"Endocr Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41571-022-00696-0","article-title":"Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies","volume":"20","author":"Kawasaki","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12155138","article-title":"A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management","volume":"12","author":"Sultana","year":"2023","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/pap.0000000000000433","article-title":"Updates on urinary bladder tumors with neuroendocrine features","volume":"31","author":"Akbulut","year":"2024","journal-title":"Adv Anatomic Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s49879","article-title":"Clinical outcome of primary small cell carcinoma of the urinary bladder","volume":"6","author":"Hou","year":"2013","journal-title":"OncoTargets Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2025.103126","article-title":"A case report of primary large cell neuroendocrine carcinoma of the urinary bladder","volume":"62","author":"Liu","year":"2025","journal-title":"Urol Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-04166-1","article-title":"Bladder paraganglioma: basic characteristics and new perspectives on perioperative management","volume":"40","author":"Cai","year":"2022","journal-title":"World J Urol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s175286","article-title":"Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study","volume":"10","author":"Niu","year":"2018","journal-title":"Cancer Manage Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04274-z","article-title":"CT and MRI findings of small cell neuroendocrine carcinoma of the urinary bladder: comparison with urothelial carcinoma","volume":"49","author":"Kawaguchi","year":"2024","journal-title":"Abdominal Radiol (New York)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24148","article-title":"Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer","volume":"39","author":"Kobayashi","year":"2014","journal-title":"J Magnetic Resonance Imaging JMRI"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2014.08.012","article-title":"Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer","volume":"83","author":"Zhou","year":"2014","journal-title":"Eur J Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.655752","article-title":"Diagnosis and molecular profiles of large cell neuroendocrine carcinoma with potential targets for therapy","volume":"11","author":"Popper","year":"2021","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2478\/raon-2021-0055","article-title":"Bladder paraganglioma: CT and MR imaging characteristics in 16 patients","volume":"56","author":"Zhang","year":"2021","journal-title":"Radiol Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.humpath.2020.01.004","article-title":"The applicability and utility of immunohistochemical biomarkers in bladder pathology","volume":"98","author":"Akgul","year":"2020","journal-title":"Hum Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14213","article-title":"Urinary tract large cell neuroendocrine carcinoma: diagnostic, prognostic and therapeutic issues","volume":"40","author":"Sanguedolce","year":"2020","journal-title":"Anticancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102495","article-title":"Synaptophysin, CD117, and GATA3 as a diagnostic immunohistochemical panel for small cell neuroendocrine carcinoma of the urinary tract","volume":"14","author":"Kim","year":"2022","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1309\/n5n5y8vd90w91wqp","article-title":"How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder","volume":"128","author":"Vakar-Lopez","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.896989","article-title":"Neoadjuvant chemotherapy in neuroendocrine bladder cancer: a case report","volume":"17","author":"Prelaj","year":"2016","journal-title":"Am J Case Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4812453","article-title":"Rare occurrence of a poorly differentiated neuroendocrine tumor of the bladder","volume":"2017","author":"Dowd","year":"2017","journal-title":"Case Rep Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2025.111045","article-title":"Small cell neuroendocrine tumor of the urinary bladder: a case report","volume":"128","author":"Shetty","year":"2025","journal-title":"Int J Surg Case Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2022.05.005","article-title":"Long-term outcomes of local and metastatic small cell carcinoma of the urinary bladder and genomic analysis of patients treated with neoadjuvant chemotherapy","volume":"20","author":"Teo","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.clgc.2023.02.009","article-title":"Urinary neuroendocrine neoplasms treated in the \"Modern Era\": a multicenter retrospective review","volume":"21","author":"Le","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01407-9","article-title":"Large cell neuroendocrine lung carcinoma: consensus statement from the British Thoracic Oncology Group and the Association of Pulmonary Pathologists","volume":"125","author":"Lindsay","year":"2021","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2017.01.007","article-title":"A review on the evolution of PD-1\/PD-L1 immunotherapy for bladder cancer: the future is now","volume":"54","author":"Bellmunt","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2346::AID-CNCR24>3.0.CO;2-5","article-title":"Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation","volume":"86","author":"Lohrisch","year":"1999","journal-title":"Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12894-022-01130-4","article-title":"Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab","volume":"22","author":"Kamitani","year":"2022","journal-title":"BMC Urol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13283","article-title":"Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas","volume":"35","author":"Gile","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100557","article-title":"Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell\/neuroendocrine carcinoma with prognostic implications","volume":"37","author":"Akbulut","year":"2024","journal-title":"Modern Pathol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1841019\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:49:14Z","timestamp":1785905354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1841019\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":32,"alternative-id":["10.3389\/fonc.2026.1841019"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1841019","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1841019"}}